To unravel the molecular mechanism responsible for the modulation of glioma cell survival and apoptosis by APPL2, we first examined the pattern of cellular signaling upon knockdown of APPL2 in LN229 and U87MG cells under conditions of low serum availability. The gene discussed is APPL2; the disease is central nervous system cancer.